Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer (Q34394972)

1 August 2017

Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer (English)

1 reference

1 August 2017

Bruce H Haughey

1

1 reference

PubMed ID

22926949

1 August 2017

Parul Sinha

series ordinal

2

1 reference

PubMed ID

22926949

1 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

1 August 2017

1 reference

1 August 2017

122 Suppl 2

1 reference

1 August 2017

S13-33

1 reference

Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Carcinoma of the tongue base treated by transoral laser microsurgery, part one: Untreated tumors, a prospective analysis of oncologic and functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Transoral robotic surgery and human papillomavirus status: Oncologic results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Prognostic importance of comorbidity in a hospital-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Predictors of cessation in a cohort of current and former smokers followed over 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Prognostic value of metastatic lymph node ratio in node-positive head and neck carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

The concurrent chemoradiation paradigm--general principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23493

21 January 2018

Identifiers

DOI

10.1002/LARY.23493

1 reference

1 August 2017

1 reference

PubMed ID

22926949